These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19377280)

  • 21. Tumour immunotherapy: the adjuvant treatment of the 21st century?
    Bremers AJ; Kuppen PJ; Parmiani G
    Eur J Surg Oncol; 2000 Jun; 26(4):418-24. PubMed ID: 10873365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of antigenic epitopes recognized by Mac-2 binding protein-specific cytotoxic T lymphocytes for use in cancer immunotherapy.
    Ozaki Y; Kontani K; Teramoto K; Fujita T; Tezuka N; Sawai S; Watanabe H; Fujino S; Asai T; Ohkubo I
    Biochem Biophys Res Commun; 2004 May; 317(4):1089-95. PubMed ID: 15094380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degeneracy instead of specificity: is this a solution to cancer immunotherapy?
    Schultze JL
    Trends Immunol; 2002 Jul; 23(7):343-4; author reply 344-5. PubMed ID: 12103351
    [No Abstract]   [Full Text] [Related]  

  • 24. Cancer immunotherapy by local transfer of autologous T lymphocytes cultured with T cell growth factor and autologous tumor extract: a clinical trial.
    Kan N; Ohgaki K; Yamasaki N; Hori T; Nakayama N; Nio Y; Inamoto T; Hikasa Y
    Nihon Geka Hokan; 1983 Nov; 52(6):841-53. PubMed ID: 6380446
    [No Abstract]   [Full Text] [Related]  

  • 25. Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncology.
    Crescioli S; Chiaruttini G; Mele S; Ilieva KM; Pellizzari G; Spencer DIR; Gardner RA; Lacy KE; Spicer JF; Tutt ANJ; Wagner GK; Karagiannis SN
    J Allergy Clin Immunol; 2018 Apr; 141(4):1519-1523.e9. PubMed ID: 29360527
    [No Abstract]   [Full Text] [Related]  

  • 26. A new era for cancer immunotherapy based on the genes that encode cancer antigens.
    Rosenberg SA
    Immunity; 1999 Mar; 10(3):281-7. PubMed ID: 10204484
    [No Abstract]   [Full Text] [Related]  

  • 27. Making the most of mucin: a novel target for tumor immunotherapy.
    Barratt-Boyes SM
    Cancer Immunol Immunother; 1996 Nov; 43(3):142-51. PubMed ID: 9001567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer.
    Jäger D; Jäger E; Knuth A
    J Clin Pathol; 2001 Sep; 54(9):669-74. PubMed ID: 11533070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a new MAGE-A10 antigenic peptide presented by HLA-A*0201 on tumor cells.
    Jia ZC; Tian Y; Huang ZM; Wang JX; Fu XL; Ni B; Wu YZ
    Cancer Biol Ther; 2011 Feb; 11(4):395-400. PubMed ID: 21124073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour immunology: dealing with regulators.
    Bordon Y
    Nat Rev Immunol; 2013 Dec; 13(12):846-7. PubMed ID: 24232463
    [No Abstract]   [Full Text] [Related]  

  • 31. [T Lymphocytes with Modified Specificity in the Therapy of Malignant Diseases].
    Vdovin AS; Bykova NA; Efimov GA
    Mol Biol (Mosk); 2017; 51(6):1008-1023. PubMed ID: 29271964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapy.
    Lu C; Meng S; Jin Y; Zhang W; Li Z; Wang F; Wang-Johanning F; Wei Y; Liu H; Tu H; Su D; He A; Cao X; Zhou F
    Br J Haematol; 2017 Aug; 178(3):413-426. PubMed ID: 28508448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer immunotherapy with MAGE antigens.
    Coulie PG
    Suppl Tumori; 2002; 1(4):S63-5. PubMed ID: 12415826
    [No Abstract]   [Full Text] [Related]  

  • 34. Expression, purification and characterization of the cancer-germline antigen GAGE12I: a candidate for cancer immunotherapy.
    Gjerstorff MF; Besir H; Larsen MR; Ditzel HJ
    Protein Expr Purif; 2010 Oct; 73(2):217-22. PubMed ID: 20546897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer-testis antigens in tumor biology and immunotherapy.
    Clark CE; Vonderheide RH
    Cancer Biol Ther; 2006 Sep; 5(9):1226-7. PubMed ID: 17021387
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of tumor-regression antigens in melanoma.
    Kawakami Y; Robbins PF; Wang RF; Rosenberg SA
    Important Adv Oncol; 1996; ():3-21. PubMed ID: 8791125
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibody Therapies in Cancer.
    Wang S; Jia M
    Adv Exp Med Biol; 2016; 909():1-67. PubMed ID: 27240456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy.
    Paterson Y; Guirnalda PD; Wood LM
    Semin Immunol; 2010 Jun; 22(3):183-9. PubMed ID: 20299242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in immunotherapy of multiple myeloma: from the discovery of tumor-associated antigens to clinical trials.
    Chiriva-Internati M; Cobos E; Kast WM
    Int Rev Immunol; 2007; 26(3-4):197-222. PubMed ID: 17558744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anti-tumor immune response induced by a combination of MAGE-3/MAGE-n-derived peptides.
    Zhang XM; Zhang YF; Huang Y; Qu P; Ma B; Si SY; Li ZS; Li WX; Li X; Ge W; Hu PZ; Sui YF
    Oncol Rep; 2008 Jul; 20(1):245-52. PubMed ID: 18575744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.